Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility

Maurice P. Zeegers, Harry Ostrer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

One of the most investigated low-penetrance genes is the androgen receptor gene. A recent meta-analysis showed however that the absolute difference in number of repeats between cases and controls was less than one repeat. This result has questioned whether the androgen receptor gene could be functionally important in prostate cancer etiology. The authors hypothesize that genes that are downstream from the androgen receptor gene, potentially those involved in testosterone response, could be of more interest. One of the primary responses of prostate cells to testosterone is the production of polyamines. Recently, a meta-analysis across gene-expression profiling studies found that genes in the polyamine biosynthesis pathway appear to be consistently dysregulated in prostate cancer. Polyamines are also involved in prostate diagnosis and treatment. Therefore, the authors suggest that future oncologic research to identify candidate regions for prostate cancer should focus on genes dysregulated in this pathway.

Original languageEnglish (US)
Pages (from-to)683-688
Number of pages6
JournalFuture Oncology
Volume1
Issue number5
DOIs
StatePublished - Oct 2005
Externally publishedYes

Fingerprint

Polyamines
Prostatic Neoplasms
Androgen Receptors
Genes
Testosterone
Meta-Analysis
Prostate
Penetrance
Gene Expression Profiling
Research

Keywords

  • androgens
  • expression profiling
  • genetic susceptibility
  • polyamines
  • prostate cancer
  • putrescine
  • spermidine
  • spermine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility. / Zeegers, Maurice P.; Ostrer, Harry.

In: Future Oncology, Vol. 1, No. 5, 10.2005, p. 683-688.

Research output: Contribution to journalArticle

@article{350998e121d64d73b5f614b8c567549f,
title = "Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility",
abstract = "One of the most investigated low-penetrance genes is the androgen receptor gene. A recent meta-analysis showed however that the absolute difference in number of repeats between cases and controls was less than one repeat. This result has questioned whether the androgen receptor gene could be functionally important in prostate cancer etiology. The authors hypothesize that genes that are downstream from the androgen receptor gene, potentially those involved in testosterone response, could be of more interest. One of the primary responses of prostate cells to testosterone is the production of polyamines. Recently, a meta-analysis across gene-expression profiling studies found that genes in the polyamine biosynthesis pathway appear to be consistently dysregulated in prostate cancer. Polyamines are also involved in prostate diagnosis and treatment. Therefore, the authors suggest that future oncologic research to identify candidate regions for prostate cancer should focus on genes dysregulated in this pathway.",
keywords = "androgens, expression profiling, genetic susceptibility, polyamines, prostate cancer, putrescine, spermidine, spermine",
author = "Zeegers, {Maurice P.} and Harry Ostrer",
year = "2005",
month = "10",
doi = "10.2217/14796694.1.5.683",
language = "English (US)",
volume = "1",
pages = "683--688",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility

AU - Zeegers, Maurice P.

AU - Ostrer, Harry

PY - 2005/10

Y1 - 2005/10

N2 - One of the most investigated low-penetrance genes is the androgen receptor gene. A recent meta-analysis showed however that the absolute difference in number of repeats between cases and controls was less than one repeat. This result has questioned whether the androgen receptor gene could be functionally important in prostate cancer etiology. The authors hypothesize that genes that are downstream from the androgen receptor gene, potentially those involved in testosterone response, could be of more interest. One of the primary responses of prostate cells to testosterone is the production of polyamines. Recently, a meta-analysis across gene-expression profiling studies found that genes in the polyamine biosynthesis pathway appear to be consistently dysregulated in prostate cancer. Polyamines are also involved in prostate diagnosis and treatment. Therefore, the authors suggest that future oncologic research to identify candidate regions for prostate cancer should focus on genes dysregulated in this pathway.

AB - One of the most investigated low-penetrance genes is the androgen receptor gene. A recent meta-analysis showed however that the absolute difference in number of repeats between cases and controls was less than one repeat. This result has questioned whether the androgen receptor gene could be functionally important in prostate cancer etiology. The authors hypothesize that genes that are downstream from the androgen receptor gene, potentially those involved in testosterone response, could be of more interest. One of the primary responses of prostate cells to testosterone is the production of polyamines. Recently, a meta-analysis across gene-expression profiling studies found that genes in the polyamine biosynthesis pathway appear to be consistently dysregulated in prostate cancer. Polyamines are also involved in prostate diagnosis and treatment. Therefore, the authors suggest that future oncologic research to identify candidate regions for prostate cancer should focus on genes dysregulated in this pathway.

KW - androgens

KW - expression profiling

KW - genetic susceptibility

KW - polyamines

KW - prostate cancer

KW - putrescine

KW - spermidine

KW - spermine

UR - http://www.scopus.com/inward/record.url?scp=34548434128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548434128&partnerID=8YFLogxK

U2 - 10.2217/14796694.1.5.683

DO - 10.2217/14796694.1.5.683

M3 - Article

C2 - 16556045

AN - SCOPUS:34548434128

VL - 1

SP - 683

EP - 688

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 5

ER -